Genetic basis of cancer of the kidney: disease-specific approaches to therapy. - Wikidata - awgldk - TriplyDB

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

http://www.wikidata.org/entity/Q34551360

about

Nucleostemin mRNA is expressed in both normal and malignant renal tissues The roles of chromatin-remodelers and epigenetic modifiers in kidney cancer U19/Eaf2 binds to and stabilizes von hippel-lindau protein.MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma.Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma.Efficacy and safety of sunitinib on metastatic renal cell carcinoma: a single-institution experience.The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR.Protein expression profiling in the spectrum of renal cell carcinomas.The changing face of renal-cell carcinoma.2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.The contributions of HIF-target genes to tumor growth in RCC.Long-term management of bilateral, multifocal, recurrent renal carcinoma.MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism Familial renal cancer: molecular genetics and surgical management.Incidence and prognostic significance of second primary cancers in renal cell carcinoma.Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma.Peripheral gammadelta T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma.Bioinformatics analysis and expression study of fumarate hydratase in lung cancer.Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.Anti-angiogenic therapy in renal cell cancer.Multiple cutaneous and uterine leiomyomatosis syndrome: a review.Novel therapies in genitourinary cancer: an update.Renal tumors: the good, the bad, and the ugly.Metastatic non-clear cell renal cell carcinoma: current therapeutic options.Hereditary renal cell carcinoma associated with von Hippel-Lindau disease: a description of a Nova Scotia cohort Carbonic anhydrase IX as a predictive biomarker of response to kidney cancer therapy.The clinical implications of the genetics of renal cell carcinoma Hereditary kidney cancer: unique opportunity for disease-based therapy.Management of metastatic renal cell carcinoma: current trends.Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma.How I treat renal cell carcinoma.Preoperative nomogram predicting 12-year probability of metastatic renal cancer.RLIP76 Targeted Therapy for Kidney Cancer Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.Biomarkers to predict response to sunitinib therapy and prognosis in metastatic renal cell cancer.Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.

P2860

Q24651568-C887367E-D61B-44B3-9D57-33E27F9EB0E7 Q28083152-63DE5AC0-C743-4047-A367-C9A97AAE444A Q33590977-C9DE286B-47B6-47BC-B200-3091F3D0E364 Q33804675-A418B1F4-E76B-48C1-8C73-BDC6B2B3B25B Q33913967-E06B1CE8-5669-438F-8A56-C5CD77DBAAC2 Q34009449-813B6697-C81A-4B38-8409-DD036B45910E Q34031245-14799605-1900-4F77-8D94-CE035D263CD3 Q34231695-2F5F5B55-6B25-40A9-9D9A-F0B8F2EC4D9F Q34246490-24C53AB9-59BF-46CE-8D75-C522A051A9F8 Q34734139-892F5D83-F10B-46AE-BF83-A2ADF039AEBD Q34760926-BD22E917-DFE3-45E0-B041-0DBBAB143322 Q35049084-B9EAD621-A5D8-49FA-B31B-2DCDB8373769 Q35189563-B034A593-2642-4903-A491-4FBF98C06CAF Q35669189-12C2E673-47B0-405C-9B47-30B368572381 Q35687676-C3B51B5E-A62D-4B6B-A71C-80FDEF6C2A9A Q36060549-FC81D12D-0775-462D-A902-75F48334BC29 Q36165800-5BEF5E6C-0338-4C20-B45B-B70A3A441F11 Q36169098-DE6D4682-671E-4E16-8536-40F452803F2A Q36334874-7525D57C-A876-426F-964A-906194941A2E Q36439412-EC25921F-9B9D-4B18-92A2-0CC0AB91B4BD Q36472613-6C2B0C61-3919-477F-914C-394BB5F4AEC7 Q36597063-ED6D9849-56B6-4C22-8D97-321598EBB6FA Q36680692-D1EB9896-76F1-4D91-B53C-712461755811 Q36794815-5542180E-D05A-4A4B-AE07-05F95F511404 Q36802596-C5893DFA-5964-4112-B83C-B035E809B55F Q36856612-E4793245-7550-4548-9CCC-8394251C6EE4 Q36889178-9468E233-885A-4E51-9A37-02A881EB7DDC Q37074247-900AF4C3-08C2-4CAA-8A97-B22A29134D48 Q37104837-089F8173-CA72-487C-808E-9FDE690DC4B3 Q37145171-408B0575-AFD0-45CF-86E8-681C50F2C7C7 Q37201797-A49A284A-A992-4AE2-AA59-A1679F82F126 Q37287088-582604E8-A468-4ACF-812A-068B73B74BBD Q37355884-280008CA-587D-4605-89EE-71D551D4629B Q37414808-95695880-70C1-40AD-BE6D-798E4D1ECF17 Q37477056-355B6F70-BEEE-4942-AEFA-91969FAD0015 Q37700441-AA95BD00-751E-4DAD-A09D-5BDFE26FD956 Q37741408-47F7305B-E4DC-4D9E-BFA2-BD05554968E9 Q37765586-5D4F8C5A-6603-4507-B850-63BFA80B55B5 Q37910970-E28C7939-1D43-4A9B-B1D6-CD69EB132C2A Q38081379-8EDC10F3-F076-4D5A-A894-6BE886CFA059

P2860

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

http://www.wikidata.org/entity/Q34551360

description

2004 nî lūn-bûn

@nan

2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@ast

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@en

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@nl

type

label

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@ast

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@en

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@nl

prefLabel

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@ast

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@en

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

@nl

P1433

Q34551360-22B84C02-ED29-4C64-8F41-8F5D604A7E06

P1476

Q34551360-5594779D-C732-4454-B3DA-09294433613D

P2093

Q34551360-1B0A4693-CABE-4BAD-9E24-C0DD9307409E

Q34551360-24796E29-1D27-4FCE-B09C-1AE0B0251400

Q34551360-28DE8069-8190-433C-BE48-3827A4A051DE

Q34551360-2CD5976F-2167-4F9C-9682-AB36AF77A962

Q34551360-328EBFBC-D9FC-4C0E-85A4-700917FDECC7

Q34551360-3F7D9738-B00D-4A5A-A4FC-FE5699A6641C

Q34551360-40268906-DAEF-4C1C-BF1C-057DED79B251

Q34551360-48B38FF0-DF1B-4B58-B3E0-40B531349CE0

Q34551360-6978293E-3536-4644-910B-CEE598F8B32A

Q34551360-6C38E3E2-04F1-4199-9E7D-D5666E7E0BE8

P304

Q34551360-AEC5C070-F74C-4EFD-8B7F-6888B93317B4

P31

Q34551360-230383C3-27BB-479D-8077-F8FD12E67365

P356

Q34551360-F447D71A-B1C9-4CA4-A6CC-0A2519487597

P407

Q34551360-7249C435-CD1D-4C70-8EFC-40B340C8CD9D

P433

Q34551360-194E7239-6493-49D7-AE99-C6C943C37EDC

P478

Q34551360-D243303A-30A3-466E-A5AB-C97E4964E943

P50

Q34551360-509229DB-5C59-49FB-A361-DB174EE25AB7

P577

Q34551360-B47D0F13-20B1-4D27-AE00-FD83F66130F3

P698

Q34551360-643E72AC-C22E-4C90-B081-2D5721C4CB97

P356

1078-0432.CCR-050013

P1433

Clinical Cancer Research

P1476

Genetic basis of cancer of the kidney: disease-specific approaches to therapy

@en

P2093

Berton Zbar

http://www.w3.org/2001/XMLSchema#string

Cathy Vocke

http://www.w3.org/2001/XMLSchema#string

Gladys Glenn

http://www.w3.org/2001/XMLSchema#string

James Vasselli

http://www.w3.org/2001/XMLSchema#string

Jennifer S Isaacs

http://www.w3.org/2001/XMLSchema#string

Jorge Toro

http://www.w3.org/2001/XMLSchema#string

Laura Schmidt

http://www.w3.org/2001/XMLSchema#string

Len Neckers

http://www.w3.org/2001/XMLSchema#string

Maria Merino

http://www.w3.org/2001/XMLSchema#string

McClellan M Walther

http://www.w3.org/2001/XMLSchema#string

P304

6282S-9S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-050013

http://www.w3.org/2001/XMLSchema#string

P407

P433

18 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Donald P. Bottaro

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15448018

http://www.w3.org/2001/XMLSchema#string